世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

皮膚科・美容院向けボツリヌス毒素の世界市場に関する洞察、2028年までの予測


Global Botulinum Toxins in Dermatology and Cosmetology Market Insights, Forecast to 2028

市場分析と洞察。皮膚科と美容院におけるボツリヌス毒素の世界市場 COVID-19の大流行により、皮膚科・美容院におけるボツリヌス毒素の世界市場規模は2022年に百万米ドル相当と推定され、2022-2028年の予測期間中... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年6月17日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析と洞察。皮膚科と美容院におけるボツリヌス毒素の世界市場
COVID-19の大流行により、皮膚科・美容院におけるボツリヌス毒素の世界市場規模は2022年に百万米ドル相当と推定され、2022-2028年の予測期間中にCAGR%で、2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮すると、2021年に皮膚科・美容院におけるボツリヌス毒素世界市場の%を占めた医療は、2028年までに百万米ドルの価値を持ち、2022年から2028年まで修正された%のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して%CAGRに変更されています。

中国の皮膚科・美容院におけるボツリヌス毒素の市場規模は2021年に百万米ドルと評価され、米国とヨーロッパの皮膚科・美容院におけるボツリヌス毒素は、それぞれ百万米ドルと百万米ドルです。米国の割合は2021年に%、中国とヨーロッパはそれぞれ%、%であり、中国の割合は2028年に%に達すると予測され、分析期間2022-2028年を通じてCAGRは%であると追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの皮膚科・美容院におけるボツリヌス毒素の状況としては、ドイツは2028年までに100万米ドルに達すると予測され、予測期間2022年から2028年にかけてCAGR %を推移しています。
皮膚科学と美容学におけるボツリヌス毒素の世界的な主要メーカーは、Allergan、Ipsen、Medytox、LIBP、Merz Pharmaceuticals、US World Meds、Hugel、Daewoongなどである。2021年、世界の上位5社は売上高で約 % のシェアを持っています。

皮膚科・美容科におけるボツリヌス毒素の世界的な範囲とセグメント
皮膚科・美容分野のボツリヌス毒素市場は、タイプ別と用途別に区分されています。世界の皮膚科・化粧品用ボツリヌス毒素市場におけるプレイヤー、利害関係者、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
メディカル
コスメティック

用途別セグメント
病院
ビューティーサロン

会社別
Allergan
イプセン
メディトックス
LIBP
メルツ・ファーマシューティカルズ
USワールドメッズ
ヒュ-ゲル
大雄

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Botulinum Toxins in Dermatology and Cosmetology Product Introduction
1.2 Market by Type
1.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medical
1.2.3 Cosmetic
1.3 Market by Application
1.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Beauty Salon
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales Estimates and Forecasts 2017-2028
2.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Estimates and Forecasts 2017-2028
2.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region
2.4.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2017-2022)
2.4.2 Global Sales Botulinum Toxins in Dermatology and Cosmetology by Region (2023-2028)
2.5 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region
2.5.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2017-2022)
2.5.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Manufacturers
3.1.1 Global Top Botulinum Toxins in Dermatology and Cosmetology Manufacturers by Sales (2017-2022)
3.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Botulinum Toxins in Dermatology and Cosmetology in 2021
3.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturers
3.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturers (2017-2022)
3.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Botulinum Toxins in Dermatology and Cosmetology Revenue in 2021
3.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Botulinum Toxins in Dermatology and Cosmetology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Botulinum Toxins in Dermatology and Cosmetology Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type
4.1.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Sales by Type (2017-2022)
4.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Sales by Type (2023-2028)
4.1.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Type (2017-2028)
4.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type
4.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Revenue by Type (2017-2022)
4.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Revenue by Type (2023-2028)
4.2.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Type (2017-2028)
4.3 Global Botulinum Toxins in Dermatology and Cosmetology Price by Type
4.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Price by Type (2017-2022)
4.3.2 Global Botulinum Toxins in Dermatology and Cosmetology Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application
5.1.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Sales by Application (2017-2022)
5.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Sales by Application (2023-2028)
5.1.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Application (2017-2028)
5.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application
5.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Revenue by Application (2017-2022)
5.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Revenue by Application (2023-2028)
5.2.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Application (2017-2028)
5.3 Global Botulinum Toxins in Dermatology and Cosmetology Price by Application
5.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Price by Application (2017-2022)
5.3.2 Global Botulinum Toxins in Dermatology and Cosmetology Price Forecast by Application (2023-2028)
6 North America
6.1 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
6.1.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
6.1.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
6.2 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
6.2.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
6.2.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
6.3 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
6.3.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
6.3.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
7.1.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
7.1.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
7.2 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
7.2.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
7.2.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
7.3 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
7.3.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
7.3.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
8.1.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
8.1.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
8.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
8.2.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
8.2.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
8.3 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Region
8.3.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2017-2028)
8.3.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
9.1.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
9.1.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
9.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
9.2.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
9.2.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
9.3 Latin America Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
9.3.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
9.3.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
10.1.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
10.1.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
10.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
10.2.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
10.2.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
10.3 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
10.3.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
10.3.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Ipsen
11.2.1 Ipsen Corporation Information
11.2.2 Ipsen Overview
11.2.3 Ipsen Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ipsen Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ipsen Recent Developments
11.3 Medytox
11.3.1 Medytox Corporation Information
11.3.2 Medytox Overview
11.3.3 Medytox Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medytox Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medytox Recent Developments
11.4 LIBP
11.4.1 LIBP Corporation Information
11.4.2 LIBP Overview
11.4.3 LIBP Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LIBP Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LIBP Recent Developments
11.5 Merz Pharmaceuticals
11.5.1 Merz Pharmaceuticals Corporation Information
11.5.2 Merz Pharmaceuticals Overview
11.5.3 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merz Pharmaceuticals Recent Developments
11.6 US World Meds
11.6.1 US World Meds Corporation Information
11.6.2 US World Meds Overview
11.6.3 US World Meds Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 US World Meds Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 US World Meds Recent Developments
11.7 Hugel
11.7.1 Hugel Corporation Information
11.7.2 Hugel Overview
11.7.3 Hugel Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hugel Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hugel Recent Developments
11.8 Daewoong
11.8.1 Daewoong Corporation Information
11.8.2 Daewoong Overview
11.8.3 Daewoong Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Daewoong Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Daewoong Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Botulinum Toxins in Dermatology and Cosmetology Industry Chain Analysis
12.2 Botulinum Toxins in Dermatology and Cosmetology Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Botulinum Toxins in Dermatology and Cosmetology Production Mode & Process
12.4 Botulinum Toxins in Dermatology and Cosmetology Sales and Marketing
12.4.1 Botulinum Toxins in Dermatology and Cosmetology Sales Channels
12.4.2 Botulinum Toxins in Dermatology and Cosmetology Distributors
12.5 Botulinum Toxins in Dermatology and Cosmetology Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Botulinum Toxins in Dermatology and Cosmetology Industry Trends
13.2 Botulinum Toxins in Dermatology and Cosmetology Market Drivers
13.3 Botulinum Toxins in Dermatology and Cosmetology Market Challenges
13.4 Botulinum Toxins in Dermatology and Cosmetology Market Restraints
14 Key Findings in The Global Botulinum Toxins in Dermatology and Cosmetology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Botulinum Toxins in Dermatology and Cosmetology Market
Due to the COVID-19 pandemic, the global Botulinum Toxins in Dermatology and Cosmetology market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Medical accounting for % of the Botulinum Toxins in Dermatology and Cosmetology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Botulinum Toxins in Dermatology and Cosmetology market size is valued at US$ million in 2021, while the US and Europe Botulinum Toxins in Dermatology and Cosmetology are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Botulinum Toxins in Dermatology and Cosmetology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Botulinum Toxins in Dermatology and Cosmetology include Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, US World Meds, Hugel and Daewoong, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Botulinum Toxins in Dermatology and Cosmetology Scope and Segment
Botulinum Toxins in Dermatology and Cosmetology market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Botulinum Toxins in Dermatology and Cosmetology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Medical
Cosmetic

Segment by Application
Hospital
Beauty Salon

By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Botulinum Toxins in Dermatology and Cosmetology Product Introduction
1.2 Market by Type
1.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medical
1.2.3 Cosmetic
1.3 Market by Application
1.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Beauty Salon
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales Estimates and Forecasts 2017-2028
2.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Estimates and Forecasts 2017-2028
2.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region
2.4.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2017-2022)
2.4.2 Global Sales Botulinum Toxins in Dermatology and Cosmetology by Region (2023-2028)
2.5 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region
2.5.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2017-2022)
2.5.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Manufacturers
3.1.1 Global Top Botulinum Toxins in Dermatology and Cosmetology Manufacturers by Sales (2017-2022)
3.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Botulinum Toxins in Dermatology and Cosmetology in 2021
3.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturers
3.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturers (2017-2022)
3.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Botulinum Toxins in Dermatology and Cosmetology Revenue in 2021
3.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Botulinum Toxins in Dermatology and Cosmetology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Botulinum Toxins in Dermatology and Cosmetology Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type
4.1.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Sales by Type (2017-2022)
4.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Sales by Type (2023-2028)
4.1.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Type (2017-2028)
4.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type
4.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Revenue by Type (2017-2022)
4.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Revenue by Type (2023-2028)
4.2.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Type (2017-2028)
4.3 Global Botulinum Toxins in Dermatology and Cosmetology Price by Type
4.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Price by Type (2017-2022)
4.3.2 Global Botulinum Toxins in Dermatology and Cosmetology Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application
5.1.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Sales by Application (2017-2022)
5.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Sales by Application (2023-2028)
5.1.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Application (2017-2028)
5.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application
5.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Historical Revenue by Application (2017-2022)
5.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Forecasted Revenue by Application (2023-2028)
5.2.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Application (2017-2028)
5.3 Global Botulinum Toxins in Dermatology and Cosmetology Price by Application
5.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Price by Application (2017-2022)
5.3.2 Global Botulinum Toxins in Dermatology and Cosmetology Price Forecast by Application (2023-2028)
6 North America
6.1 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
6.1.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
6.1.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
6.2 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
6.2.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
6.2.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
6.3 North America Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
6.3.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
6.3.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
7.1.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
7.1.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
7.2 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
7.2.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
7.2.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
7.3 Europe Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
7.3.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
7.3.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
8.1.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
8.1.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
8.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
8.2.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
8.2.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
8.3 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Market Size by Region
8.3.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2017-2028)
8.3.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
9.1.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
9.1.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
9.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
9.2.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
9.2.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
9.3 Latin America Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
9.3.1 Latin America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
9.3.2 Latin America Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Type
10.1.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2017-2028)
10.1.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2017-2028)
10.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Application
10.2.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2017-2028)
10.2.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2017-2028)
10.3 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Market Size by Country
10.3.1 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2017-2028)
10.3.2 Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Ipsen
11.2.1 Ipsen Corporation Information
11.2.2 Ipsen Overview
11.2.3 Ipsen Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ipsen Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ipsen Recent Developments
11.3 Medytox
11.3.1 Medytox Corporation Information
11.3.2 Medytox Overview
11.3.3 Medytox Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medytox Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medytox Recent Developments
11.4 LIBP
11.4.1 LIBP Corporation Information
11.4.2 LIBP Overview
11.4.3 LIBP Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LIBP Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LIBP Recent Developments
11.5 Merz Pharmaceuticals
11.5.1 Merz Pharmaceuticals Corporation Information
11.5.2 Merz Pharmaceuticals Overview
11.5.3 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merz Pharmaceuticals Recent Developments
11.6 US World Meds
11.6.1 US World Meds Corporation Information
11.6.2 US World Meds Overview
11.6.3 US World Meds Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 US World Meds Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 US World Meds Recent Developments
11.7 Hugel
11.7.1 Hugel Corporation Information
11.7.2 Hugel Overview
11.7.3 Hugel Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hugel Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hugel Recent Developments
11.8 Daewoong
11.8.1 Daewoong Corporation Information
11.8.2 Daewoong Overview
11.8.3 Daewoong Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Daewoong Botulinum Toxins in Dermatology and Cosmetology Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Daewoong Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Botulinum Toxins in Dermatology and Cosmetology Industry Chain Analysis
12.2 Botulinum Toxins in Dermatology and Cosmetology Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Botulinum Toxins in Dermatology and Cosmetology Production Mode & Process
12.4 Botulinum Toxins in Dermatology and Cosmetology Sales and Marketing
12.4.1 Botulinum Toxins in Dermatology and Cosmetology Sales Channels
12.4.2 Botulinum Toxins in Dermatology and Cosmetology Distributors
12.5 Botulinum Toxins in Dermatology and Cosmetology Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Botulinum Toxins in Dermatology and Cosmetology Industry Trends
13.2 Botulinum Toxins in Dermatology and Cosmetology Market Drivers
13.3 Botulinum Toxins in Dermatology and Cosmetology Market Challenges
13.4 Botulinum Toxins in Dermatology and Cosmetology Market Restraints
14 Key Findings in The Global Botulinum Toxins in Dermatology and Cosmetology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20 10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る